Date: 2016-04-05
Type of information: Nomination
Compound:
Company: Intarcia Therapeutics (USA - CA)
Therapeutic area: Metabolic diseases
Type agreement: nomination
Action mechanism:
Disease:
Details: * On April 5th, 2016, Intarcia Therapeutics announced Anthony Hurley has joined the Company in the role of VP, Global Commercial Manufacturing and Operations, based in Hayward, CA. Tony is an executive officer of the Company and serves as a member of the Leadership Team, reporting directly to Chairman, President and CEO, Kurt Graves. Most recently Tony served as Genentech’s VP, Head of Global External Manufacturing – Biologics. He spent the last eleven years of his career at Genentech in positions of increasing responsibility including Head of South San Francisco Manufacturing Operations and Head of Global Quality Biologics for both Drug Substance and Drug Product. Anthony Hurley's immediate responsibilities at Intarcia will be to provide the manufacturing support for the potential global launch of Intarcia’s novel drug-device platform to treat type 2 diabetes. Specifically, Mr. Hurley will lead and continue to build out the commercial manufacturing team necessary to accomplish the commercial production/scale-up and facility expansions in the US and abroad. The new position is part of Intarcia’s rapid expansion to bring new capabilities in-house. Mr. Hurley will serve as an executive leader in the company broadly, shouldering a large and mission-critical responsibility for the scale-up of ITCA 650 for our planned global launch. Tony and the rest of the team in Hayward will also finalize plans and important work on our second manufacturing facility in Ireland, and eventually progressing our novel pipeline programs when they reach the right stage of development.
Prior to his decade-long career in senior positions at Genentech, Inc., Mr. Hurley spent seventeen years in positions of increasing responsibility at GSK from 1987 to 2004, beginning as a Primary Plant Process Engineer and advancing through the ranks to his most senior role as Site Director, Upper Merion Anti-Infectives Operations, where he oversaw 280 employees. Before this, Tony spent two years as at Schering Plough as a Pilot Plant Engineer/Supervisor.
Mr. Hurley received his B.Sc. degree in Chemical Engineering at the Cork Institute of Technology, Cork, Ireland, and his M.Sc. Degree in Industrial Engineering from Rutgers University, NJ.
Financial terms:
Latest news:
